Finance

Lists
Why is NSB down 6,45%?
Dive Deeper
NSB:ASX
Neuroscientific Biopharmaceuticals Ltd
0,058 AUD
-6,45%
(-0,0040) 1D
2-окт., 15:16:50 GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for NSB...
Open
0,06 AUD
High
0,06 AUD
Low
0,06 AUD
Mkt. cap
22,98 млн
Avg. vol.
120,20 миң
Volume
186,82 миң
52-wk high
0,18 AUD
52-wk low
0,06 AUD
EPS
-0,01 AUD
Shares outstanding
389,72 млн
Open
0,06 AUD
High
0,06 AUD
Low
0,06 AUD
Mkt. cap
22,98 млн
Avg. vol.
120,20 миң
Volume
186,82 миң
52-wk high
0,18 AUD
52-wk low
0,06 AUD
EPS
-0,01 AUD
Shares outstanding
389,72 млн
News stories
From web sources and news partners
About Neuroscientific Biopharmaceuticals Ltd
CEO-
Employees-
Founded2002
Headquarters-
Sector-
Last report
2026-ж., 28-июл.
Fiscal period
Q4 2026
EPS / Est. (AUD)
- / -
Revenue / Est. (AUD)
42,38 миң / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
158,95 миң
158,95 миң
42,38 миң
42,38 миң
Cost of goods sold
23,53 миң
23,53 миң
48,66 миң
48,66 миң
Cost of revenue
23,53 миң
23,53 миң
48,66 миң
48,66 миң
Research and development expenses
225,61 миң
225,61 миң
316,20 миң
316,20 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
409,06 миң
409,06 миң
628,30 миң
628,30 миң
Operating expense
1,04 млн
1,04 млн
1,44 млн
1,44 млн
Total operating expenses
1,07 млн
1,07 млн
1,49 млн
1,49 млн
Operating income
-908,64 миң
-908,64 миң
-1,44 млн
-1,44 млн
Other non operating income
-
-
-
-
EBT including unusual items
-849,71 миң
-849,71 миң
-1,50 млн
-1,50 млн
EBT excluding unusual items
-849,71 миң
-849,71 миң
-1,39 млн
-1,39 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-849,71 миң
-849,71 миң
-1,50 млн
-1,50 млн
Net profit margin
-534,56%
-534,56%
-3 532,28%
-3 532,28%
Earnings per share
-
-
-
-
Interest and investment income
59,20 миң
59,20 миң
54,17 миң
54,17 миң
Interest expense
-263,00
-263,00
-1,57 миң
-1,57 миң
Net interest expenses
58,94 миң
58,94 миң
52,60 миң
52,60 миң
Depreciation and amortization charges
383,00
383,00
6,24 миң
6,24 миң
EBITDA
-597,26 миң
-597,26 миң
-1,06 млн
-1,06 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору